.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,608,245

« Back to Dashboard

Details for Patent: 7,608,245

Title:Methods for manipulating satiety
Abstract: Disclosed is a method of manipulating the rate of upper gastrointestinal transit of a substance in a mammal. Also disclosed are methods of manipulating satiety and post-prandial visceral blood flow. A method of treating visceral pain or visceral hypersensitivity in a human subject is also described. A method for prolonging the residence time of an orally or enterally administered substance by promoting its dissolution, bioavailability and/or absorption in the small intestine is also described. These methods are related to a method of transmitting to and replicating at a second location in the central nervous system a serotonergic neural signal originating at a first location in the proximal or distal gut of a mammal and/or a method of transmitting to and replicating at a second location in the upper gastrointestinal tract a serotonergic neural signal originating at a first location in the proximal or distal gut.
Inventor(s): Lin; Henry C. (Manhattan Beach, CA)
Assignee: Cedars-Sinai Medical Center (Los Angeles, CA)
Filing Date:Jul 13, 2006
Application Number:11/457,445
Claims:1. A method for treating obesity in a mammalian subject comprising administering a peptide that binds to the Y1, Y2, Y4 or Y5 PYY receptor to said mammal.

2. The method of claim 1 wherein said mammalian subject is a human.

3. The method of claim 2 wherein said peptide is administered mucosally.

4. The method of claim 3 wherein said peptide is administered by an oral delivery route.

5. The method of claim 2 wherein said peptide is administered parenterally.

6. The method of claim 1 wherein said peptide is comprised of the amino acid sequence as disclosed by SEQ ID NO:1.

7. A method for treating obesity in a human subject comprising parenterally administering to said human a peptide that binds to the Y1, Y2, Y4 or Y5 PYY receptor at a dose of from about 0.5 to about 500 picomoles/kg weight of the subject wherein said peptide is comprised of the amino acid sequence as disclosed by SEQ ID NO:1.

8. A method of inducing satiety in a mammalian subject comprising administering a peptide that binds to the Y1, Y2, Y4 or Y5 PYY receptor to said mammalian subject.

9. The method of claim 8 wherein said subject is a human.

10. The method of claim 9 wherein said peptide is administered mucosally.

11. The method of claim 10 wherein the peptide is administered orally.

12. The method of claim 8 wherein the peptide is administered parenterally.

13. The method of claim 8 wherein said peptide is comprised of the amino acid sequence as disclosed by SEQ ID NO:1.

14. A method for inducing satiety in a human subject comprising parenterally administering to said subject a peptide that binds to the Y1, Y2, Y4 or Y5 PYY receptor at a dose of from about 0.5 to about 500 picomoles/kg weight of the subject wherein said peptide is comprised of the amino acid sequence as disclosed by SEQ ID NO:1.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc